Tin tức & Cập nhật

Chỉ hiển thị Multimedia
ARTISTRY-1 supports switch from complex HIV regimen to a novel single pill
ARTISTRY-1 supports switch from complex HIV regimen to a novel single pill
04 Mar 2026 bởiAudrey Abella

The phase II/III open-label ARTISTRY-1 trial shows that people living with HIV (PWH) may simplify their complex regimen (CR) by switching to a novel daily single-tablet regimen (STR) comprising bictegravir and lenacapavir (BIC+LEN).

ARTISTRY-1 supports switch from complex HIV regimen to a novel single pill
04 Mar 2026